Plain-English translation of NCT00796146 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand what happens in the very first weeks and months after someone is infected with HIV. By following people who have just been diagnosed with acute HIV infection and collecting blood samples and health information over time, scientists hope to learn more about how the virus behaves early on and how the body's immune system responds. This knowledge could help lead to better vaccines and treatments in the future.
Most HIV research has focused on people who have had the virus for a long time. But the earliest weeks of infection are critical for understanding how HIV establishes itself in the body and how the immune system initially responds. By studying this acute phase, researchers hope to gain insights that could lead to more effective vaccines and immunological treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would be asked to visit the clinic many times over the first several months, then less frequently after that, with follow-up potentially lasting up to about 4 years. At each visit, you'll have blood drawn to check your immune system and viral levels, complete a brief questionnaire, and possibly have urine tests. The research team may ask you to stay in the hospital for the first 3 to 7 days after enrollment for closer monitoring. Blood samples and immune cells will be saved for future research studies that may help develop new treatments.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Thailand